Stephen Raskin

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel et al. · Science · 2020 · 1.6K citations

Life Sciences, Immunology, Oncology +17

RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Talia Golan, Elina Zorde Khvalevsky, Ayala Hubert et al. · Oncotarget · 2015 · 326 citations · Full text

Medicine, Oncology, Pharmacology +12

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

Bradley E. Aouizerat, Medha Kulkarni, David C. Heilbron et al. · Journal of Lipid Research · 2003 · 118 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Effects of Integrelin, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist, in Unstable Angina

Steven P. Schulman, Pascal J. Goldschmidt‐Clermont, Eric J. Topol et al. · Circulation · 1996 · 109 citations

Medicine, Cardiology, Pharmacology +16

Neoadjuvant pembrolizumab (Pembro) for early stage non-small cell lung cancer (NSCLC): Updated report of a phase I study, MK3475-223.

Jair Bar, Damien Urban, Efrat Ofek et al. · Journal of Clinical Oncology · 2019 · 40 citations

Pharmacy, Oncology, Pharmacotherapy +16